NHINYSEReal Estate Investment TrustsFiscal year ends December 31

NATIONAL HEALTH INVESTORS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$64.70−1.58 (-2.38%)

Close on Oct 19, 2026

Market cap: $3.14B
P/E (TTM): 18.7
Dividend yield: 5.38%

NATIONAL HEALTH INVESTORS INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Revenue	376	335	320	278	299	333	318	295	279	248	229	178	118	93	84	83	63	57
General & Administrative	27	21	19	23	18	13	13	13	12	9.77	11	9.11	9.25	7.80	7.59	7.79	5.26	3.59
Operating Expenses	239	212	201	242	216	162	157	140	127	130	102	74	42	25	24	21	14	12
Operating Income	–	–	–	–	–	–	–	–	–	–	150	103	79	73	70	62	49	45
Interest Expense	57	60	58	45	51	53	56	49	46	43	38	26	9.23	3.49	3.85	1.55	–	–
Interest & Investment Income	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.16	0.08	1.24	–
Income from Equity Investments	3.66	0.40	0.56	0.57	-1.55	-3.13	0	0	0	-1.21	-1.77	-0.07	0.32	0.05	0	0	–	–
Other Non-Operating Income	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.60	0.57	0.27	–
Asset Impairment Charges	–	–	–	–	52	–	–	–	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Investments	–	6.26	–	–	–	–	0	0	10	30	24	0	0	0.03	9.90	0	2.40	0.41
Pretax Income	–	–	–	–	–	–	161	155	151	119	127	103	76	68	60	62	–	–
Income Tax Expense	–	–	–	–	–	–	–	0.14	0.12	0.85	-0.58	0.12	0.12	0.27	0.10	0.08	–	–
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	–	149	102	78	73	70	62	57	51
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	–	0	0	28	18	11	7.64	7.17	6.71
Net Income incl. Noncontrolling Interests	141	137	134	66	112	185	160	154	159	153	150	103	107	91	81	69	–	–
Minority Interest in Earnings	-1.39	-1.35	-1.27	-0.90	0.16	0.19	-0.01	0	0	1.18	1.45	1.44	1.00	0.17	0	0	–	–
Net Income	142	138	136	66	112	185	160	154	159	152	149	102	106	91	81	69	64	58
Net Income to Common	142	138	136	66	112	–	–	–	–	–	–	–	–	–	–	–	–	–
EPS (Basic)(per share)	3.03	3.14	3.13	1.48	2.45	4.14	3.70	3.68	3.90	3.88	3.96	3.04	3.74	3.26	2.93	2.51	2.33	2.08
EPS (Diluted)(per share)	3.02	3.13	3.13	1.48	2.44	4.14	3.67	3.67	3.87	3.87	3.95	3.04	3.74	3.26	2.92	2.50	2.32	2.07
Shares Outstanding (Basic, Weighted)(shares)	47	44	43	45	46	45	43	42	41	39	38	33	28	28	28	28	28	28
Shares Outstanding (Diluted, Weighted)(shares)	47	44	43	45	46	45	44	42	41	39	38	33	28	28	28	28	28	28
Dividend per Share(per share)	3.48	2.84	3.60	3.60	3.80	4.41	4.20	4.00	3.80	3.60	3.40	3.08	3.12	2.64	2.72	2.36	2.30	2.42
Net Interest Income	–	–	269	240	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Provision for Credit Losses	–	–	–	11	0.19	0.59	–	–	–	–	–	–	–	0	0	0	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: –
Net margin: 38.6%
Return on equity, FY2025: 9.8%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: 18.7
Price to sales: 7.26
Price to book: 2.00
Dividend yield: 5.38%